ADCC effected by PBMCs of patients receiving KM871. Patients received 1, 5, 10, 20, or 40 mg/m² KM871 biweekly infusions. Results (mean ± SD) from analyses in the presence of 1 µg/mL KM871 at an E:T ratio of 50:1 are shown.